Strong Growth Forecast for China’s Robotic Surgical Systems Sector

Expect double-digit growth in China’s robotic surgical systems market in the next decade as the country’s aging population and artificial intelligence (AI)-powered technology fuel demand for better surgical interventions, a GlobalData analysis predicts.

The company is forecasting a 12% compound annual growth rate through 2036. Its report, “Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” shows that China accounted for roughly 30% of the Asia-Pacific robotic surgical systems market in 2024, driven by the growing demand for advanced surgical technologies.

The recent regulatory approval of Shanghai-based Ronovo Surgical’s Carina robotic platform marks a significant milestone in China’s surgical robotics industry. Unlike conventional systems, Carina’s modular design offers flexibility in instrument selection and anatomical access, enabling tailored robotic-assisted surgeries across multiple specialties including urology, gynecology, thoracic, and general surgery. This versatility enhances the accessibility and cost-effectiveness of robotic-assisted surgical procedures for hospitals.

“This development underscores China’s commitment to foster in-house innovation in the field of surgical robotics, reducing operational expenses and reliance on imported devices,” GlobalData Medical Devices Analyst Jyoti Sharma said. “This reduction could allow a greater number of healthcare facilities to integrate robotic systems, thereby enhancing surgical precision.”

Beyond Ronovo Surgical, international companies have also expanded their footprint in China’s robotic surgery market. Johnson & Johnson’s Monarch robotic system received approval in 2023 for peripheral lung procedures, and Stereotaxis’ Genesis robot was cleared in 2024. These authorizations underscore the growing accessibility of various robotic-assisted technologies in China, offering hospitals additional options to enhance surgical results.

“With the ongoing investment and an increasing number of regulatory approvals, the Chinese robotic surgical systems market is well-positioned for sustained growth. As increasing number of hospitals integrate these advanced systems, better patient outcomes and more favorable recovery experiences are expected. This progress will further solidify China’s role as a significant contributor to the dynamic field of robotic-assisted surgery,” Sharma stated.